Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rowan T Chlebowski

Showing results (241-250 of 366) with videos related to

Pageof 37
Sort By:
The New England Journal of Medicine|March 5, 2004
Estrogen plus progestin and colorectal cancer in postmenopausal womenRowan T Chlebowski, Jean Wactawski-Wende, Cheryl Ritenbaugh, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 22, 2024
Menopausal Hormone Therapy and Ovarian and Endometrial Cancers: Long-Term Follow-Up of the Women's Health Initiative Randomized TrialsRowan T Chlebowski, Aaron K Aragaki, Kathy Pan, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 19, 2024
Estrogen Plus Progestin and Colorectal Cancer: Long-Term Findings From the Women's Health Initiative Randomized Clinical TrialRowan T Chlebowski, Aaron K Aragaki, Kathy Pan, et al.
Journal of the American Geriatrics Society|January 14, 2011
Interaction between body mass index and central adiposity and risk of incident cognitive impairment and dementia: results from the Women's Health Initiative Memory StudyDiana R Kerwin, Sarah A Gaussoin, Rowan T Chlebowski, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|July 2, 2009
A longitudinal study of the metabolic syndrome and risk of postmenopausal breast cancerGeoffrey C Kabat, Mimi Kim, Rowan T Chlebowski, et al.
International Journal of Cancer|July 10, 2009
Repeated measures of serum glucose and insulin in relation to postmenopausal breast cancerGeoffrey C Kabat, Mimi Kim, Bette J Caan, et al.
Breast Cancer Research and Treatment|November 3, 2016
Accounting for individualized competing mortality risks in estimating postmenopausal breast cancer riskMara A Schonberg, Vicky W Li, A Heather Eliassen, et al.
Journal of the National Cancer Institute|September 7, 2023
Validating a model for predicting breast cancer and nonbreast cancer death in women aged 55 years and olderEmily A Wolfson, Mara A Schonberg, A Heather Eliassen, et al.
American Journal of Public Health|October 19, 2013
Women's health initiative view of estrogen avoidance and all-cause mortalityRoss L Prentice, Joann E Manson, Garnet L Anderson, et al.
JAMA|March 6, 2008
Health risks and benefits 3 years after stopping randomized treatment with estrogen and progestinGerardo Heiss, Robert Wallace, Garnet L Anderson, et al.
Pageof 37

Showing results (241-250 of 366) with videos related to

Sort By:
Pageof 37
The New England Journal of Medicine|March 5, 2004
Estrogen plus progestin and colorectal cancer in postmenopausal womenRowan T Chlebowski, Jean Wactawski-Wende, Cheryl Ritenbaugh, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 22, 2024
Menopausal Hormone Therapy and Ovarian and Endometrial Cancers: Long-Term Follow-Up of the Women's Health Initiative Randomized TrialsRowan T Chlebowski, Aaron K Aragaki, Kathy Pan, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 19, 2024
Estrogen Plus Progestin and Colorectal Cancer: Long-Term Findings From the Women's Health Initiative Randomized Clinical TrialRowan T Chlebowski, Aaron K Aragaki, Kathy Pan, et al.
Journal of the American Geriatrics Society|January 14, 2011
Interaction between body mass index and central adiposity and risk of incident cognitive impairment and dementia: results from the Women's Health Initiative Memory StudyDiana R Kerwin, Sarah A Gaussoin, Rowan T Chlebowski, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|July 2, 2009
A longitudinal study of the metabolic syndrome and risk of postmenopausal breast cancerGeoffrey C Kabat, Mimi Kim, Rowan T Chlebowski, et al.
International Journal of Cancer|July 10, 2009
Repeated measures of serum glucose and insulin in relation to postmenopausal breast cancerGeoffrey C Kabat, Mimi Kim, Bette J Caan, et al.
Breast Cancer Research and Treatment|November 3, 2016
Accounting for individualized competing mortality risks in estimating postmenopausal breast cancer riskMara A Schonberg, Vicky W Li, A Heather Eliassen, et al.
Journal of the National Cancer Institute|September 7, 2023
Validating a model for predicting breast cancer and nonbreast cancer death in women aged 55 years and olderEmily A Wolfson, Mara A Schonberg, A Heather Eliassen, et al.
American Journal of Public Health|October 19, 2013
Women's health initiative view of estrogen avoidance and all-cause mortalityRoss L Prentice, Joann E Manson, Garnet L Anderson, et al.
JAMA|March 6, 2008
Health risks and benefits 3 years after stopping randomized treatment with estrogen and progestinGerardo Heiss, Robert Wallace, Garnet L Anderson, et al.
Pageof 37